CN105878977A - Ginger and periostracum cicada composition and applications thereof - Google Patents
Ginger and periostracum cicada composition and applications thereof Download PDFInfo
- Publication number
- CN105878977A CN105878977A CN201610161764.8A CN201610161764A CN105878977A CN 105878977 A CN105878977 A CN 105878977A CN 201610161764 A CN201610161764 A CN 201610161764A CN 105878977 A CN105878977 A CN 105878977A
- Authority
- CN
- China
- Prior art keywords
- zingiberis recens
- rhizoma zingiberis
- cicadae
- radix
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 37
- 235000006886 Zingiber officinale Nutrition 0.000 title abstract description 5
- 235000008397 ginger Nutrition 0.000 title abstract description 5
- 241000931705 Cicada Species 0.000 title abstract 4
- 244000273928 Zingiber officinale Species 0.000 title description 2
- 241000222336 Ganoderma Species 0.000 claims abstract description 9
- 239000000463 material Substances 0.000 claims abstract description 6
- 210000004369 blood Anatomy 0.000 claims description 10
- 239000003814 drug Substances 0.000 claims description 10
- 241000628997 Flos Species 0.000 claims description 9
- 239000008280 blood Substances 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 8
- 206010061218 Inflammation Diseases 0.000 claims description 5
- 230000004054 inflammatory process Effects 0.000 claims description 5
- 239000012567 medical material Substances 0.000 claims description 5
- 208000031226 Hyperlipidaemia Diseases 0.000 claims description 4
- 206010005963 Bone formation increased Diseases 0.000 claims description 3
- 208000004930 Fatty Liver Diseases 0.000 claims description 3
- 206010019708 Hepatic steatosis Diseases 0.000 claims description 3
- 208000010706 fatty liver disease Diseases 0.000 claims description 3
- 239000012467 final product Substances 0.000 claims description 3
- 231100000240 steatosis hepatitis Toxicity 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 2
- 239000004299 sodium benzoate Substances 0.000 claims description 2
- 235000010234 sodium benzoate Nutrition 0.000 claims description 2
- LPNITZFOZWXKMB-UHFFFAOYSA-N acetic acid;molecular chlorine Chemical compound ClCl.CC(O)=O LPNITZFOZWXKMB-UHFFFAOYSA-N 0.000 claims 1
- 241000234314 Zingiber Species 0.000 abstract 3
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 abstract 1
- 235000010894 Artemisia argyi Nutrition 0.000 abstract 1
- 241001435059 Artemisia argyi Species 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 244000241872 Lycium chinense Species 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 241001300193 Speranskia Species 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 238000002560 therapeutic procedure Methods 0.000 description 8
- 238000011282 treatment Methods 0.000 description 8
- 241000700159 Rattus Species 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000011148 porous material Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 229910001385 heavy metal Inorganic materials 0.000 description 3
- 201000001421 hyperglycemia Diseases 0.000 description 3
- 230000002218 hypoglycaemic effect Effects 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- 210000004243 sweat Anatomy 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 241000208340 Araliaceae Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 241000700157 Rattus norvegicus Species 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 229940126678 chinese medicines Drugs 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 240000005528 Arctium lappa Species 0.000 description 1
- 235000003130 Arctium lappa Nutrition 0.000 description 1
- 235000008078 Arctium minus Nutrition 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 235000004360 Dioscorea zingiberensis Nutrition 0.000 description 1
- 241001678283 Dioscorea zingiberensis Species 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 230000003749 cleanliness Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000035617 depilation Effects 0.000 description 1
- 238000011697 diabetes animal model Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- WWULHQLTPGKDAM-UHFFFAOYSA-N gamma-eudesmol Natural products CC(C)C1CC(O)C2(C)CCCC(=C2C1)C WWULHQLTPGKDAM-UHFFFAOYSA-N 0.000 description 1
- NLDDIKRKFXEWBK-AWEZNQCLSA-N gingerol Chemical compound CCCCC[C@H](O)CC(=O)CCC1=CC=C(O)C(OC)=C1 NLDDIKRKFXEWBK-AWEZNQCLSA-N 0.000 description 1
- JZLXEKNVCWMYHI-UHFFFAOYSA-N gingerol Natural products CCCCC(O)CC(=O)CCC1=CC=C(O)C(OC)=C1 JZLXEKNVCWMYHI-UHFFFAOYSA-N 0.000 description 1
- 235000002780 gingerol Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 229960002275 pentobarbital sodium Drugs 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/234—Cnidium (snowparsley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/904—Stemonaceae (Stemona family), e.g. croomia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Insects & Arthropods (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a ginger and periostracum cicada composition. The ginger and periostracum cicada composition is prepared from the following medicinal materials: fresh ginger, periostracum cicada, radix sophorae flavescentis, safflower carthamus, herba artemisia argyi, radix stemonae, radix arnebiae seu lithospermi, tubearculate speranskia herb, lucid ganoderma, the fruits of Chinese wolfberry, rhizoma ligustici wallichii, cortex phellodendri, herba artemisiae scopariae, fructus forsythiae, fructus cnidii and fructus arctii.
Description
Technical field
The invention provides a kind of Rhizoma Zingiberis Recens Cicadae compositions and application thereof, belong to field of medicaments.
Background technology
Rhizoma Zingiberis Recens treatment is a kind of common external application physical therapy mode of present medical treatment, health preserving industry, is usually and Rhizoma Zingiberis Recens is polished into paste
Shape or be fabricated to the products such as quintessence oil, directly Rhizoma Zingiberis Recens mud dressing on body skin, wraps with plastic fresh-keeping membrane, or Rhizoma Zingiberis Recens
Quintessence oil processed drops in and spreads out massage on health, by the component content of Jiang Benshen: gingerol, zingiberol, oil of ginger terpene etc., accelerates health blood
Liquid circulates, and dispels body and trembles with fear.Common Rhizoma Zingiberis Recens treats the character utilizing Rhizoma Zingiberis Recens relieving exterior syndrome and dispelling cold, can dispel " ailment said due to cold or exposure " and " damp ", nurses one's health human body
Inner loop, treatment or relief of symptoms.
Common Rhizoma Zingiberis Recens is treated has simplicity, cheap, rapid-action, the feature of few side effects, but shortcoming is also apparent from: 1, can only dispel
The raw symptom of the shallow table of human body, it is impossible to go deep into disease source；2, composition uniformity, the composition only with Jiang Benshen plays a role, reason
Treatment scope is little, and the cold effect on moisture extraction of row is the most notable；3, quantity of perspiration is few, it is impossible to thoroughly get rid of cold-damp and heavy metal element；4, reality should
Not there is in antiinflammation；5, effect unicity, can only get rid of cold-damp etc., it is impossible to supplement human body so nutrient；6、
Do not carry out the sterilization treatment that sterilizes, use safety without ensureing.
Summary of the invention
Rhizoma Zingiberis Recens known in the art treats effect can only dispel the raw of health shallow-layer, induces sweat and cannot go deep into internal disease source,
And Rhizoma Zingiberis Recens Cicadae compositions of the present invention, repeatedly further investigate experiment by Lin Shi Rhizoma Zingiberis Recens Cicadae is steamed bone therapy, (preferably plateau is yellow to utilize Rhizoma Zingiberis Recens
Rhizoma Zingiberis Recens), Cicadae with ten number taste specially good effect rare Chinese medicines combine, be possible not only to dispel health shallow-layer cold-damp heresy disease, it is often more important that
Formula, through through nanotechnology treatments, utilizes the pungent element of plateau Dioscorea zingiberensis that pore is backed down, and medicine gas penetrates corium along pore
Layer straight arrival sutura, the dampness in sutura, cold is steamed out formation perspiration and excretes, thus reaches dredge the meridian passage, lives
Blood blood stasis dispelling, the effect of bactericidal antiphlogistic, thoroughly solve disease source.
It is that a people sleeps on the Rhizoma Zingiberis Recens of eight jin that Rhizoma Zingiberis Recens Cicadae steams the characteristic of bone therapy, and this formula make use of nanotechnology, passes through Rhizoma Zingiberis Recens
Effect and the effect of Periostracum Cicadae are got through whole body meridian and epidermis, corium, capillary blood pore are opened medicine gas to penetrate skin corium along pore straight
Arrive sutura, thoroughly internal wind, cold-damp, malicious and carcinogenic heavy metal, pull out from bone seam by the way of perspiring.
Relative to known Rhizoma Zingiberis Recens treatment technology, Rhizoma Zingiberis Recens Cicadae compositions of the present invention and corresponding Rhizoma Zingiberis Recens Cicadae steaming bone therapy feature:
1, by nanotechnology, the cold-damp of internal deep layer is thoroughly dispelled, through sutura and disease source；
2, diversity, utilizing the characteristic of Jiang Benshen to be combined with ten number taste rare Chinese medicines can full relief physical symptom；
What 3, Rhizoma Zingiberis Recens Cicadae steamed bone therapy row is the sweat that temperature is the lowest, it was demonstrated that row's is cold-damp, and whole during amount of sweat big,
Effectively eliminate heavy metal of body material；
4, Rhizoma Zingiberis Recens Cicadae steam bone therapy can effectively antiinflammatory, antibacterial, removing toxic substances, reducing swelling and alleviating pain: as Flos Carthami in formula, Radix Sophorae Flavescentis antiinflammatory stop
Blood, can effectively alleviate gynecological inflammation,
5, Rhizoma Zingiberis Recens Cicadae steams bone therapy scalable body immunity, warming the kidney to invigorate YANG, beauty and bright skin.
6, product is 300,000 grades through the clean cleanliness factor of sterilization process for producing environment, meets GB15979--
2002 requirements.
Detailed Description Of The Invention
Present inventor is according to secret prescription handed down in the family from generation to generation, by validation trial, has summed up a secondary Rhizoma Zingiberis Recens Cicadae composite formula,
It is external preparation, can by human body coated medicament or make human body lie on the bed of the medicine that tiled use, for fat
Liver, hyperosteogeny, hyperlipidemia, hyperglycemia, all kinds of inflammation all have significant therapeutic effect.
One aspect of the application, it is provided that a kind of Rhizoma Zingiberis Recens Cicadae compositions, including Rhizoma Zingiberis Recens and Periostracum Cicadae.
Further aspect of the application, it is provided that a kind of Rhizoma Zingiberis Recens Cicadae compositions, including Rhizoma Zingiberis Recens, Periostracum Cicadae, Radix Sophorae Flavescentis, Flos Carthami,
Folium Artemisiae Argyi, the Radix Stemonae, Radix Arnebiae (Radix Lithospermi), Herba speranskiae tuberculatae, Ganoderma, Fructus Lycii, Rhizoma Chuanxiong, Cortex Phellodendri, Herba Artemisiae Scopariae, Fructus Forsythiae, Fructus Cnidii, ZHONGBANGZI.
Further aspect of the application, it is provided that a kind of Rhizoma Zingiberis Recens Cicadae compositions, including Rhizoma Zingiberis Recens 3800g, Periostracum Cicadae 10g, hardship
Ginseng 10g, Flos Carthami 10g, Folium Artemisiae Argyi 10g, Radix Stemonae 15g, Radix Arnebiae (Radix Lithospermi) 18g, Herba speranskiae tuberculatae 15g, Ganoderma 20g, Fructus Lycii 20g, Rhizoma Chuanxiong 20g, Cortex Phellodendri
20g, Herba Artemisiae Scopariae 30g, Fructus Forsythiae 15g, Fructus Cnidii 15g, ZHONGBANGZI 10g.
Further aspect of the application, it is provided that a kind of Rhizoma Zingiberis Recens Cicadae compositions, including Rhizoma Zingiberis Recens 3800g, Periostracum Cicadae 20g, hardship
Ginseng 20g, Flos Carthami 20g, Folium Artemisiae Argyi 20g, Radix Stemonae 5g, Radix Arnebiae (Radix Lithospermi) 10g, Herba speranskiae tuberculatae 5g, Ganoderma 15g, Fructus Lycii 10g, Rhizoma Chuanxiong 10g, Cortex Phellodendri
10g, Herba Artemisiae Scopariae 5g, Fructus Forsythiae 20g, Fructus Cnidii 25g, ZHONGBANGZI 10g.
Further aspect of the application, it is provided that the preparation method of Rhizoma Zingiberis Recens Cicadae compositions, including: 1, Rhizoma Zingiberis Recens is weighed, pulverize
To 1.8 ten thousand mesh (1000nm), standby；2, remaining medical material is weighed, be crushed to 1.8 ten thousand mesh (1000nm), place standby respectively；3、
1, the 2 standby materials of step are sufficiently mixed and stir, to obtain final product.
Further aspect of the application, can add or be added without proper amount of acetic acid hibitane in above-mentioned Rhizoma Zingiberis Recens Cicadae compositions
And/or sodium benzoate.
In preparation method of the present invention, various medical materials produce if any juice in crushing process, then collect this juice and powder
Medical material mixing for standby use after broken.
Further aspect of the application, it is provided that Rhizoma Zingiberis Recens Cicadae compositions preparation treatment fatty liver, hyperosteogeny, hyperlipidemia,
Hyperglycemia, inflammation medicine in purposes.
In use, a kind of method is that human body lies flat on the bed or lies prone in bed to Rhizoma Zingiberis Recens Cicadae compositions of the present invention,
Rhizoma Zingiberis Recens Cicadae compositions is spread upon human body surface equably, preferably spreads upon disease sites or surface, acupuncture point.Preferably, above-mentioned
Rhizoma Zingiberis Recens Cicadae compositions is powder, pureed or pasty state.
In use, a kind of method is that Rhizoma Zingiberis Recens Cicadae compositions is placed on the plastics of sealing to Rhizoma Zingiberis Recens Cicadae compositions of the present invention
In bag or in paper bag, the plastic bag or the paper bag that will be equipped with Rhizoma Zingiberis Recens Cicadae compositions tile in bed, then make patient lie low and are moulding
On pocket or paper bag.See accompanying drawing 1.
Rhizoma Zingiberis Recens Cicadae compositions of the present invention can heat or do not heat before use.Preferably, Rhizoma Zingiberis Recens Cicadae compositions of the present invention exists
Use front heating；It is highly preferred that Rhizoma Zingiberis Recens Cicadae compositions of the present invention is heated to 30-80 DEG C before use；It is highly preferred that Rhizoma Zingiberis Recens Cicadae of the present invention
Compositions is heated to 40-70 DEG C before use；It is highly preferred that Rhizoma Zingiberis Recens Cicadae compositions of the present invention is heated to 45-60 DEG C before use.
Not fettered by content of the present invention, those skilled in the art can also be in herein described Rhizoma Zingiberis Recens Cicadae compositions
On the basis of take the circumstances into consideration to add other Chinese crude drugs or compound, all in scope.
Accompanying drawing explanation
Fig. 1 is that Rhizoma Zingiberis Recens Cicadae steams bone therapy principle schematic.
Detailed description of the invention
Embodiment 1
Rhizoma Zingiberis Recens Cicadae composite formula: Rhizoma Zingiberis Recens 3800g, Periostracum Cicadae 10g, Radix Sophorae Flavescentis 10g, Flos Carthami 10g, Folium Artemisiae Argyi 10g, Radix Stemonae 15g, Radix Arnebiae (Radix Lithospermi)
18g, Herba speranskiae tuberculatae 15g, Ganoderma 20g, Fructus Lycii 20g, Rhizoma Chuanxiong 20g, Cortex Phellodendri 20g, Herba Artemisiae Scopariae 30g, Fructus Forsythiae 15g, Fructus Cnidii 15g, middle burdock
Sub-10g.
Preparation method:
1, Rhizoma Zingiberis Recens is weighed, be crushed to 1.8 ten thousand mesh (1000nm), standby；
2, remaining medical material is weighed, be crushed to 1.8 ten thousand mesh (1000nm), place standby respectively；
3,1, the 2 standby materials of step are sufficiently mixed stir, to obtain final product.
Embodiment 2
Rhizoma Zingiberis Recens Cicadae composite formula: Rhizoma Zingiberis Recens 3800g, Periostracum Cicadae 20g, Radix Sophorae Flavescentis 20g, Flos Carthami 20g, Folium Artemisiae Argyi 20g, Radix Stemonae 5g, Radix Arnebiae (Radix Lithospermi)
10g, Herba speranskiae tuberculatae 5g, Ganoderma 15g, Fructus Lycii 10g, Rhizoma Chuanxiong 10g, Cortex Phellodendri 10g, Herba Artemisiae Scopariae 5g, Fructus Forsythiae 20g, Fructus Cnidii 25g, ZHONGBANGZI
10g。
Preparation method is with embodiment 1.
Pharmacodynamic experiment
Test example 1: hypoglycemic active testing
1. test material:
Animal: male Wistar rat, Nanjing animal center provides.
Reagent: embodiment 1, embodiment 2, comparative example 1-3.
Instrument: DV650 full automatic biochemical apparatus, SHIMAZU 1601 ultraviolet-uisible spectrophotometer, micropipettor, electronics
Analytical balance, swirl mixing device.
Table 1. reagent contrasts
2. test method:
(1) prepared by diabetes animal model: 180-220g male Wistar rat 80, adaptability nursing three days, at random
Select 10 rats as Normal group.Yu 70 rat limosis 12h rear left lumbar injection streptozotocin (STZ) 60mg/kg,
All giving normal diet after injection, survey rat limosis tail vein sugar after 12h, blood glucose ＞ 16.7mmol/L is that Glycemia Decline becomes
Merit.Taking modeling winner 50 and only include test in, depilation processes, more than discard.
(2) animal packet and nursing: diabetes rat is randomly divided into 5 groups, blank group, embodiment 1 group, embodiment
2 groups, comparative example's 1-2 group, often group 10.Blank group refuses any process, embodiment 1,2 groups and comparative example 1,
2 groups carry out epidermis coating, ad lib and drinking-water with the medicine of 300g/ (kg d) respectively, do not use insulin.
(3) specimen sampling: after feeding 12 weeks, rat limosis 6h, weigh, 2% pentobarbital sodium intraperitoneal anesthesia, exoculation ball
Take blood 5ml standby.Take above-mentioned rat from blood coagulation 2ml, utilize full automatic biochemical apparatus to measure blood glucose.
3. result of the test:
Serum blood glucose:
Table 2 is respectively organized the blood sugar detection result result of rat and is shown:
Visible, embodiment 1, embodiment 2 medicine have obvious effect of lowering blood sugar.And change the right of consumption or composition
Than embodiment 1-2 group, not there is hypoglycemic activity or hypoglycemic activity is very poor.
Test example 2
Choose 15 patients between 30 to 70 years old and carry out quantum detection instrument inspection before and after the Rhizoma Zingiberis Recens Cicadae doing embodiment 1 steams bone therapy
Surveying, Testing index is as follows:
Table 3
Table 4
Table 5
From the data of table 3-table 5, Rhizoma Zingiberis Recens Cicadae compositions of the present invention all has for fatty liver, hyperglycemia, hyperlipidemia, inflammation
Have significant therapeutic effect.
Claims (7)
1. a Rhizoma Zingiberis Recens Cicadae compositions, including Rhizoma Zingiberis Recens and Periostracum Cicadae.
2. a Rhizoma Zingiberis Recens Cicadae compositions, including Rhizoma Zingiberis Recens, Periostracum Cicadae, Radix Sophorae Flavescentis, Flos Carthami, Folium Artemisiae Argyi, the Radix Stemonae, Radix Arnebiae (Radix Lithospermi), Herba speranskiae tuberculatae, Ganoderma,
Fructus Lycii, Rhizoma Chuanxiong, Cortex Phellodendri, Herba Artemisiae Scopariae, Fructus Forsythiae, Fructus Cnidii, ZHONGBANGZI.
3. a kind of Rhizoma Zingiberis Recens Cicadae compositions as claimed in claim 2, including Rhizoma Zingiberis Recens 3800g, Periostracum Cicadae 10g, Radix Sophorae Flavescentis 10g, Flos Carthami
10g, Folium Artemisiae Argyi 10g, Radix Stemonae 15g, Radix Arnebiae (Radix Lithospermi) 18g, Herba speranskiae tuberculatae 15g, Ganoderma 20g, Fructus Lycii 20g, Rhizoma Chuanxiong 20g, Cortex Phellodendri 20g, Herba Artemisiae Scopariae
30g, Fructus Forsythiae 15g, Fructus Cnidii 15g, ZHONGBANGZI 10g.
4. a kind of Rhizoma Zingiberis Recens Cicadae compositions as claimed in claim 2, including Rhizoma Zingiberis Recens 3800g, Periostracum Cicadae 20g, Radix Sophorae Flavescentis 20g, Flos Carthami
20g, Folium Artemisiae Argyi 20g, Radix Stemonae 5g, Radix Arnebiae (Radix Lithospermi) 10g, Herba speranskiae tuberculatae 5g, Ganoderma 15g, Fructus Lycii 10g, Rhizoma Chuanxiong 10g, Cortex Phellodendri 10g, Herba Artemisiae Scopariae 5g, company
Stick up 20g, Fructus Cnidii 25g, ZHONGBANGZI 10g.
5. the Rhizoma Zingiberis Recens Cicadae compositions as described in any one of claim 1-4, wherein can add or be added without proper amount of acetic acid chlorine
Determine and/or sodium benzoate.
6. the preparation method of Rhizoma Zingiberis Recens Cicadae compositions described in any one of claim 1-5, including: Rhizoma Zingiberis Recens is weighed, is crushed to 1.8 ten thousand mesh
(1000nm), standby；Remaining medical material is weighed, is crushed to 1.8 ten thousand mesh (1000nm), places standby respectively；Above-mentioned steps is standby
It is sufficiently mixed with material and stirs, to obtain final product.
7. as described in any one of claim 1-5, Rhizoma Zingiberis Recens Cicadae compositions treats fatty liver, hyperosteogeny, hyperlipidemia, high blood in preparation
Sugar, inflammation medicine in purposes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610161764.8A CN105878977A (en) | 2016-03-21 | 2016-03-21 | Ginger and periostracum cicada composition and applications thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610161764.8A CN105878977A (en) | 2016-03-21 | 2016-03-21 | Ginger and periostracum cicada composition and applications thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105878977A true CN105878977A (en) | 2016-08-24 |
Family
ID=57014544
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610161764.8A Pending CN105878977A (en) | 2016-03-21 | 2016-03-21 | Ginger and periostracum cicada composition and applications thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105878977A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114053388A (en) * | 2021-12-13 | 2022-02-18 | 西安大爱健康产业有限公司 | Preparation process of ginger preparation for promoting human health |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103446507A (en) * | 2013-09-03 | 2013-12-18 | 夏进 | Anti-inflammatory, antalgic and scar-suppressive traditional Chinese medicinal ointment |
| CN103690920A (en) * | 2013-12-25 | 2014-04-02 | 周军正 | Traditional Chinese medicinal prescription for treating nasosinusitis |
| CN104173974A (en) * | 2014-08-25 | 2014-12-03 | 河南科技大学第一附属医院 | Medicine for treating psoriasis and preparation method thereof |
-
2016
- 2016-03-21 CN CN201610161764.8A patent/CN105878977A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103446507A (en) * | 2013-09-03 | 2013-12-18 | 夏进 | Anti-inflammatory, antalgic and scar-suppressive traditional Chinese medicinal ointment |
| CN103690920A (en) * | 2013-12-25 | 2014-04-02 | 周军正 | Traditional Chinese medicinal prescription for treating nasosinusitis |
| CN104173974A (en) * | 2014-08-25 | 2014-12-03 | 河南科技大学第一附属医院 | Medicine for treating psoriasis and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 华夏久康高洁: "姜蝉骨蒸疗法", 《HTTPS://TIEBA.BAIDU.COM/P/4088956296?RED_TAG=3414239476》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114053388A (en) * | 2021-12-13 | 2022-02-18 | 西安大爱健康产业有限公司 | Preparation process of ginger preparation for promoting human health |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101797326B (en) | Chinese materia medica preparation for treating borborygmus diarrhoea and preparation method thereof | |
| CN103041209B (en) | Chinese herbal preparation for curing deficiency of kidney-yin and preparation method thereof | |
| CN101670060A (en) | Traditional Chinese medicine composition for treating such diseases as hepatic stagnation, chest stuffiness and distension and preparation method | |
| CN101810835A (en) | Chinese medicinal composition for treating purpura and preparation method thereof | |
| CN102210844B (en) | Chinese medicinal composition for treating chronic hepatitis and preparation method thereof | |
| CN103142842B (en) | Traditional Chinese medicine for treating diabetes mellitus | |
| CN104825914A (en) | Traditional Chinese medicinal preparation for assisted treatment of breast cancer | |
| CN102631595B (en) | Medicament for treating II-type diabetes mellitus and preparation method thereof | |
| CN105497261A (en) | Matrix of patch for external use and patch and sleeping-aid patch made from matrix | |
| CN101607031B (en) | Medicated wine for curing and preventing diabetes mellitus, preparation method and application method thereof | |
| CN103989996B (en) | It is a kind of to treat Chinese medicine composition of diabetes and preparation method thereof | |
| CN100509025C (en) | A medicine for treating diabetes | |
| CN104984296A (en) | Pharmaceutical composition for treating female climacteric syndrome and preparation method thereof | |
| CN105878977A (en) | Ginger and periostracum cicada composition and applications thereof | |
| CN104548049A (en) | Traditional Chinese medicine composition for treating senile osteoporosis and preparation method thereof | |
| CN102552743A (en) | Medicinal composition for treating diabetes and preparation method thereof | |
| CN103007145B (en) | Traditional Chinese medicine composition for treating children rotavirus enteritis and preparation method of composition | |
| CN102861292B (en) | Medicament for treating esophageal cancer and preparation method thereof | |
| CN104306847A (en) | Six-ingredient qi-tonifying capsule and preparation process thereof | |
| CN105362629A (en) | Female climacteric syndrome treatment pharmaceutical composition containing cortex eucommiae and preparation method of female climacteric syndrome treatment pharmaceutical composition containing cortex eucommiae | |
| CN101708230B (en) | Anti-drug medicine and preparation method thereof | |
| CN103638336A (en) | Full rhizoma gastrodiae tablet | |
| CN108853340A (en) | A kind of Chinese medicine of nourishing the liver and kidney and preparation method thereof | |
| CN111328967A (en) | Method for preparing health porridge for hyperlipidemia patients | |
| CN104257132B (en) | A kind of nursing chair prevented or treat diabetes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160824 |